Jakarta, July 8 -- Indonesia's National Research and Innovation Agency (BRIN) has described vaccine development as essential to strengthening the country's health sovereignty, expressing hope that the University of Indonesia (UI)-Tsinghua University collaboration on an mRNA dengue vaccine will stimulate further domestic innovation.

BRIN Head Arif Satria said on Wednesday that the launch of the vaccine prototype represents more than a scientific milestone, serving as evidence of international collaboration, scientific excellence, and a shared commitment to strengthening national health resilience.

"Through this initiative, we want to strengthen Indonesia's capacity to develop vaccine technology domestically, accelerate its application, a...